Opinion|Videos|August 28, 2024
Communicating PDT Benefits to Patients and Clinician Training for Implementation
Author(s)Arwen Podesta, MD
Experts discuss the importance of effective patient communication regarding prescription digital therapeutics (PDTs), the need for clinician training prior to PDT implementation, and key considerations for healthcare providers when prescribing these digital interventions.
Advertisement
Episodes in this series
- How do you communicate with patients about the benefits of PDTs and how to use PDTs?
- What training may be needed for clinicians prior to implementing PDTs?
- What are some considerations that clinicians should keep in mind when prescribing PDTs?
Advertisement
Related to this article
Only 19.1% of commercially insured patients with first-episode psychosis were adherent to antipsychotics in the year after starting treatment.
Prioritizing referral completion as much as referral generation will equip organizations to measure results and improve health outcomes.
Daiichi Sankyo and Merck pulled their bid for accelerated approval of I-DXd in small cell lung cancer after the FDA found phase 2 data fell short.
In this discussion, Chad Hatfield, Pharm.D., M.H.A., BCPS, shares his perspective on the evolving role of pharmacy services and the value of collaboration across health care.
CMS transparency rules and AI could bring “Expedia-like” drug price comparisons for consumers, but payer compliance to transparency rules remains low.
Dunn of NeosRx says a 340B shift from discounts to rebates likely won't affect rebate erosion affecting plan sponsors.
Five transcranial magnetic stimulation sessions in one day improved processing speed in adults with schizophrenia, which holds promise for future treatment possibilities, according to researcher Heather Burrell Ward, M.D.
Imaging has been associated with four of the five most prevalent low-value services among Medicare beneficiaries.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Daiichi Sankyo, Merck withdraw bid for accelerated approval of I-DXd in small cell lung cancer
2
Why consumers still can’t comparison shop for medication
3
The hidden costs of routine radiology and how they can be addressed
4
When the referral isn't the finish line: Making SDOH programs actually close care gaps
5